Alkem Laboratories' board has declared an interim dividend of ₹43 per equity share for FY2025-26, representing a 2150% payout on the ₹2 face value.

To be eligible, investors must hold shares by the record date of February 20, 2026. The dividend payment is scheduled to commence on March 6, 2026. This move clearly benefits shareholders, reflecting the company's commitment to returning value.

The board also approved the financial results for the quarter and nine-month period.